Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Unexpected Toxicities When Nivolumab Was Given after Allogeneic Stem Cell Transplantation

Amy Wang, MD MPH, Justin Kline, MD, Wendy Stock, MD, Satyajit Kosuri, MD, Andrew S. Artz, MD, Richard A. Larson, MD, Peter A. Riedell, MD, Michael R. Bishop, MD, Hongtao Liu, MD PhD

Blood (2019) 134 (Supplement_1): 1956.

https://doi.org/10.1182/blood-2019-123887

Published: 2019

Journal Articles

Hypoxia Dependent and Independent Dysregulation of the Transcriptome in Sickle Cell Anemia

Xu Zhang, PhD, Jihyun Song, PhD, Binal N. Shah, Taif Hassan, Galina Miasnikova, MD, Adelina Sergueeva, MD, Josef T. Prchal, MD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 2262.

https://doi.org/10.1182/blood-2019-132078

Published: 2019

Journal Articles

Autoimmune Markers in Children with Chronic Immune Thrombocytopenia

Tuba Nur Tahtakesen Güçer, MD, Ali Aycicek, MD, Gonul Aydogan, MD, Zafer Salcioglu, Ebru Yilmaz, Cengiz Bayram, MD, Gul Nihal Nihal Ozdemir, MD

Blood (2018) 132 (Supplement 1): 2447.

https://doi.org/10.1182/blood-2018-99-109839

Published: 2018

Journal Articles

Diagnostic Relevance of 18F-FDG PET/CT in Newly Diagnosed Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) : Single- Center Experience

Viera Sandecka, MD PhD, Ludek Pour, MD, Zdenek Adam, Prof, MD CSc, Martin Stork, MD, Marta Krejci, Prof, MD PhD, Jana Michalcova, MD, Zdenek Kral, MD CSc, Sabina Sevcikova, PhD, Zdeněk Řehák, MD PhD, Renata Koukalova, MD

Blood (2018) 132 (Supplement 1): 1913.

https://doi.org/10.1182/blood-2018-99-111094

Published: 2018

Journal Articles

Inhibition of the Integrin αVβ3 Improves the Immune and Anti-Lymphoma Effects of Bexarotene in Cutaneous T-Cell Lymphoma (CTCL)

Maria Florencia Cayrol, Maria Mercedes Debernardi, Maria Victoria Revuelta, PhD, Alejandra Paulazo, Maria Nieves Calvo Vidal, PhD, Jude M Phillip, DPhil, Helena Sterle, Maria Celeste Diaz Flaque, Graciela Cremaschi, Leandro Cerchietti, MD

Blood (2017) 130 (Supplement 1): 732.

https://doi.org/10.1182/blood.V130.Suppl_1.732.732

Published: 2017

Journal Articles

Thyroid hormone regulates hematopoiesis via the TR-KLF9 axis

Blood (2017) 130 (20): 2161–2170.

https://doi.org/10.1182/blood-2017-05-783043

Published: 2017

Includes: Supplemental data

Journal Articles

Thyroid Hormone Receptor Beta and NCOA4 Regulate Terminal Erythrocyte Differentiation

Hsiang-Ying Lee, PhD, Harvey F. Lodish, PhD, Xiaofei Gao, Wenbo Li, Randy Platt, Inmaculada Barrasa, Russell Elmes, Michael G. Rosenfeld

Blood (2015) 126 (23): 3590.

https://doi.org/10.1182/blood.V126.23.3590.3590

Published: 2015

Journal Articles

Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells

Florencia Cayrol, María Celeste Díaz Flaqué, Tharu Fernando, Shao Ning Yang, Helena Andrea Sterle, Marcela Bolontrade, Mariana Amorós, Blanca Isse, Ricardo Norberto Farías, Haelee Ahn, Ye F. Tian, Fabrizio Tabbò, Ankur Singh, Giorgio Inghirami, Leandro Cerchietti, Graciela Alicia Cremaschi

Blood (2015) 125 (5): 841–851.

https://doi.org/10.1182/blood-2014-07-587337

Published: 2015

Includes: Supplemental data

Journal Articles

Delineating the Nuclear Receptors Involved in Retinoid Responsiveness in CTCL Cells

Sebastian S. DeMarco, Lei Wang, JianMing Chen, Lance C. Bridges

Blood (2014) 124 (21): 5496.

https://doi.org/10.1182/blood.V124.21.5496.5496

Published: 2014

Journal Articles

Integrin αvβ3 Transduces Survival and Angiogenic Signals to T Cell Lymphomas and Is a Therapeutic Target

Maria Florencia Cayrol, PhDstudent, Maria Celeste Diaz Flaque, PhD, Tharu Fernando, PhDstudent, Shao Ning Yang, Marcela Bolontrade, PhD, Mariana Amoros, Ricardo Farias, PhD, Giorgio Inghirami, MD, Graciela Cremaschi, PhD, Leandro Cerchietti, MD

Blood (2014) 124 (21): 510.

https://doi.org/10.1182/blood.V124.21.510.510

Published: 2014

Journal Articles

Thalassemia Major and Intermedia in Older Patients – a Single Center Experience

Liat Shargian-Alon, MD, Idit Pazgal, MD, Pia Raanani, MD, Eliezer Rachmilewitz, MD, Pinhas Stark, MD

Blood (2014) 124 (21): 2685.

https://doi.org/10.1182/blood.V124.21.2685.2685

Published: 2014

Journal Articles

Combination Of Lenalidomide, Dexamethasone and Cyclophosphamide as Treatment For The First Relapse Of Multiple Myeloma: Efficacy, Toxicity and Occurance Of Thyroid Abnormalities

Marta Krejci, MD, PhD, Zdenek Adam, Prof. MD, PhD, Ludek Pour, MD, PhD, Jana Pelcova, Jiri Mayer, MD, PhD

Blood (2013) 122 (21): 3233.

https://doi.org/10.1182/blood.V122.21.3233.3233

Published: 2013

Journal Articles

Thyroid Hormones Maintain The CTCL Malignant Phenotype Through Membrane- and Nuclear-Initiated Transcriptional Programs

Maria Florencia Cayrol, PhD student, Tharu Fernando, PhD student, María Celeste Díaz Flaqué, Shao Ning Yang, Ricardo Farias, Graciela Cremaschi, Leandro Cerchietti, MD

Blood (2013) 122 (21): 3810.

https://doi.org/10.1182/blood.V122.21.3810.3810

Published: 2013

Journal Articles

Senior Labor Study: A New Definition Of Normal Hemoglobin Values In Older Healthy Individuals

Lorenz Risch, MD, MPH, Corina Risch, Pedro Medina, Urs Nydegger, Martin Risch, Jean-Francois Lambert

Blood (2013) 122 (21): 956.

https://doi.org/10.1182/blood.V122.21.956.956

Published: 2013

Journal Articles

Thyroid Hormones Antagonize and Tetrac, a Deaminated T4 Analog, Sensitizes Bortezomib Action in Multiple Myeloma Cells

Martin Ellis, MD, Keren Cohen, MSc, Shafik Khoury, MD, Paul J Davis, MD, Aleck Hercbergs, MD, Osnat Ashur-Fabian, PhD

Blood (2011) 118 (21): 2867.

https://doi.org/10.1182/blood.V118.21.2867.2867

Published: 2011

Journal Articles

Blocking Thyroid Hormones Induced MAPK Activation -Novel Target for Therapy In Myeloma

Martin Ellis, MD, Keren Cohen, BSc, Ina Fabian, PhD, Aleck Hercbergs, MD, Osnat Ashur-Fabian, PhD

Blood (2010) 116 (21): 2964.

https://doi.org/10.1182/blood.V116.21.2964.2964

Published: 2010

Journal Articles

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Cord Blood Transplantation (CBT). Retrospective Analysis on Behalf of Eurocord and the EBMT Autoimmune Diseases Working Party.

Blood (2010) 116 (21): 3460.

https://doi.org/10.1182/blood.V116.21.3460.3460

Published: 2010

Journal Articles

Low Dose Bexarotene and Ultraviolet A Photochemotherapy (PUVA) In a Prospective Phase II Clinical Study for Refractory and/or Resistant Cutaneous T Cell Lymphomas (CTCL)

Serena Rupoli, MD, Nicola Pimpinelli, MD, Gaia Goteri, MD, Lucia Canafoglia, MD, Paola Picardi, Giuliano Brandozzi, MD, Stefano Pulini, Irene Federici, PhD, Anna Rita Scortechini, md, Simona Tomassetti, MD, Lisa Albani, MD, Lidia Da Lio, MD, Mirella Giangiacomi, Pietro Leoni, MD

Blood (2010) 116 (21): 3953.

https://doi.org/10.1182/blood.V116.21.3953.3953

Published: 2010

Journal Articles

Irradiation-Induced Growth Hormone Neurosecretory Disfunction In ALL Patients

Gulay Biceroglu, Teoman Akcay, Gonul Aydogan, Arzu Akcay, Ferhan Akici, Deniz Tugcu, Zafer Salcioglu, Hulya Sayilan, Nuray Ayaz

Blood (2010) 116 (21): 4329.

https://doi.org/10.1182/blood.V116.21.4329.4329

Published: 2010

Journal Articles

Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study

Bregje van Zaane, Alessandro Squizzato, Roeland Huijgen, Anton P. van Zanten, Eric Fliers, Suzanne C. Cannegieter, Harry R. Büller, Victor E. A. Gerdes, Dees P. M. Brandjes

Blood (2010) 115 (22): 4344–4349.

https://doi.org/10.1182/blood-2009-11-253724

Published: 2010

NARROW

Unexpected Toxicities When Nivolumab Was Given after Allogeneic Stem Cell Transplantation

Hypoxia Dependent and Independent Dysregulation of the Transcriptome in Sickle Cell Anemia

Autoimmune Markers in Children with Chronic Immune Thrombocytopenia

Diagnostic Relevance of 18F-FDG PET/CT in Newly Diagnosed Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) : Single- Center Experience

Inhibition of the Integrin αVβ3 Improves the Immune and Anti-Lymphoma Effects of Bexarotene in Cutaneous T-Cell Lymphoma (CTCL)

Thyroid hormone regulates hematopoiesis via the TR-KLF9 axis

Thyroid Hormone Receptor Beta and NCOA4 Regulate Terminal Erythrocyte Differentiation

Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells

Delineating the Nuclear Receptors Involved in Retinoid Responsiveness in CTCL Cells

Integrin αvβ3 Transduces Survival and Angiogenic Signals to T Cell Lymphomas and Is a Therapeutic Target

Thalassemia Major and Intermedia in Older Patients – a Single Center Experience

Combination Of Lenalidomide, Dexamethasone and Cyclophosphamide as Treatment For The First Relapse Of Multiple Myeloma: Efficacy, Toxicity and Occurance Of Thyroid Abnormalities

Thyroid Hormones Maintain The CTCL Malignant Phenotype Through Membrane- and Nuclear-Initiated Transcriptional Programs

Senior Labor Study: A New Definition Of Normal Hemoglobin Values In Older Healthy Individuals

Thyroid Hormones Antagonize and Tetrac, a Deaminated T4 Analog, Sensitizes Bortezomib Action in Multiple Myeloma Cells

Blocking Thyroid Hormones Induced MAPK Activation -Novel Target for Therapy In Myeloma

Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Cord Blood Transplantation (CBT). Retrospective Analysis on Behalf of Eurocord and the EBMT Autoimmune Diseases Working Party.

Low Dose Bexarotene and Ultraviolet A Photochemotherapy (PUVA) In a Prospective Phase II Clinical Study for Refractory and/or Resistant Cutaneous T Cell Lymphomas (CTCL)

Irradiation-Induced Growth Hormone Neurosecretory Disfunction In ALL Patients

Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only